Veloxis Pharmaceuticals Announces Financial Results for the First Three Months of 2018
May 14, 2018 12:40 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 12/2018 To: Nasdaq Copenhagen A/S Copenhagen, Denmark, 14 May 2018 Veloxis Pharmaceuticals Announces Financial Results for the First Three...
FDA Accepts Veloxis’s Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR®
April 19, 2018 17:57 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 11/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 19 April 2018 FDA Accepts Veloxis’s Supplemental New...
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
April 17, 2018 01:12 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 10/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 17 April 2018 Veloxis Pharmaceuticals A/S Grants Warrants Under...
Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2018
April 13, 2018 04:24 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 09/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 13 April 2018 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2018 Summary: At Veloxis...
Veloxis Appoints Morten Marott as Chief Financial Officer
April 02, 2018 23:13 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 08/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 April 2018 Veloxis Appoints Morten Marott as Chief Financial Officer Veloxis Pharmaceuticals A/S (OMX:...
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 March 2018
March 31, 2018 06:00 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 07/2018
To: NASDAQ Copenhagen...
Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of ENVARSUS XR®
March 28, 2018 15:50 ET
|
Veloxis Pharmaceuticals A/S
Investor News no. 01/2018
To: NASDAQ Copenhagen...
Notice to Convene Annual General Meeting 2018
March 22, 2018 09:57 ET
|
Veloxis Pharmaceuticals A/S
Company Announcement no. 05/2018
To: NASDAQ Copenhagen A/S ...
Veloxis Increases Share Capital in Connection with Exercise of Warrants
March 16, 2018 00:00 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 04/2018
To: NASDAQ Copenhagen...
Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR
March 07, 2018 15:16 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 03/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 07...